AGP Picks
View all

Angela Ricketts turns her family’s choroideremia journey into a new memoir

Aug. 28, 2026
By AI, Created 14:00 UTC, Aug 28, 2026, AGP -

Author and Sight Stones founder Angela Ricketts is releasing Never Lose Sight on Aug. 28, 2026, a memoir about her son Kai’s diagnosis with choroideremia, a rare inherited retinal disease that causes progressive vision loss. Proceeds from the book will support research for inherited retinal diseases.

Why it matters: - Never Lose Sight puts a personal face on choroideremia, a rare disease that can lead to blindness and has no approved treatment. - The book also channels proceeds into research support through Sight Stones, linking storytelling with funding for inherited retinal disease work. - The release adds awareness to a condition that affects families dealing with uncertain, progressive vision loss.

What happened: - Angela Ricketts, founder of Sight Stones and mother of Kai, is releasing Never Lose Sight: Finding My Way Back to Hope Through Vision Loss, Grief, and Clay on Aug. 28, 2026. - The book tells the story of Ricketts’ family after Kai was diagnosed with choroideremia, or CHM. - The Choroideremia Research Foundation is highlighting the release and its connection to CHM awareness.

The details: - Ricketts said her five-year-old son was diagnosed in 2016 with a rare eye disease that leads to blindness, the same condition that affected her grandfather. - The memoir follows the family through loss, uncertainty and hope after the diagnosis. - Ricketts said she wrote the book after realizing hope comes from choosing what to focus on, not from having an easy life. - After Kai’s diagnosis, Ricketts began making small clay reminders to help process fear and uncertainty. - Those creations became Sight Stones, with each stone featuring a hole in the center to represent the visual field of someone living with choroideremia. - The stones can be used as touchstones or worn as necklaces and bracelets. - Ricketts’ father was an artist, and her creative work became a way to turn fear into something meaningful. - Sight Stones is now a nonprofit organization focused on supporting research for inherited retinal diseases. - Kathi Wagner, executive director of the Choroideremia Research Foundation, said Ricketts’ story reflects the resilience and determination found in the CHM community. - In the book’s epilogue, Ricketts writes that Kai taught her vulnerability can take more courage than most people find in a lifetime. - Choroideremia is caused by mutations in the CHM gene and primarily affects males. - The disease often begins with trouble seeing in low light and loss of peripheral vision before advancing to significant visual impairment. - Researchers are working to better understand CHM and develop potential therapies. - All proceeds from the book support Sight Stones’ efforts to fund research for inherited retinal diseases. - Readers can find the book on Amazon, and more information about Sight Stones is available at Sight Stones.

Between the lines: - The memoir is as much a fundraising and awareness tool as it is a personal narrative. - Ricketts is framing her family’s experience as part of a broader message for people facing illness, grief or uncertainty. - The CHM community is using books, nonprofits and research advocacy to keep attention on a disease with no approved cure.

What's next: - The book’s release will direct attention and proceeds toward Sight Stones’ research mission. - Continued research efforts remain focused on CHM therapies and broader inherited retinal disease progress. - The Choroideremia Research Foundation says it will keep supporting families, research and education around the condition.

The bottom line: - Never Lose Sight turns one family’s diagnosis into a public call for hope, awareness and research funding.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Page Turner Review

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Page Turner Review

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.